Chargement en cours...
Novel Somatostatin Receptor Ligands Therapies for Acromegaly
Surgery is considered the treatment of choice in acromegaly, but patients with persistent disease after surgery or in whom surgery cannot be considered require medical therapy. Somatostatin receptor ligands (SRLs) octreotide (OCT), lanreotide, and the more recently approved pasireotide, characterize...
Enregistré dans:
| Publié dans: | Front Endocrinol (Lausanne) |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5845985/ https://ncbi.nlm.nih.gov/pubmed/29563895 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2018.00078 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|